Table 4.
Ratio of participants with improved sleep parameters in control (placebo) and test (ACH) phases.
| Variables | Sleep Diary | Actigraphy | ||||
|---|---|---|---|---|---|---|
| Placebo | ACH | p-Value † | Placebo | ACH | p-Value † | |
| Increased TST | 24% | 79% | <0.001 ** | 41% | 61% | 0.073 |
| Decreased SL | 30% | 67% | 0.001 ** | 29% | 46% | 0.119 |
| Increased SE | 24% | 85% | <0.001 ** | 63% | 85% | 0.031 |
| Decreased WASO | 32% | 51% | 0.096 | 61% | 67% | 0.597 |
| Decreased Awakes | 43% | 54% | 0.355 | 56% | 64% | 0.465 |
Data are answered numbers (%). † p-value, chi-square test was used to analyze group difference. * q-value < 0.05 and ** q-value < 0.01, pFDR was calculated to account for multiple testing.